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1Dear audience,
The neurobiology of mood disorders has been already for decades the subject of intensive 
experimental and clinical research. Several theories have been developed to explain the 
genesis of these disorders. We believe that the different mechanisms implicated by these 
theories are not independent from one another. Therefore, we will try to describe, how 
these different theories are interrelated. This will bring us finally to a model how two 
different brain structures induce low mood. We believe that a dysfunctioning of two 
different cortical-subcortical circuits is involved in major depressive disorders. The five 
theories of mood disorders give the mechanisms of how these circuits are affected by 
genetic and environmental circumstances.
2This slides shows the five theories that have been developed to explain the mechanism of 
major depressive disorder. The first one, the monoamine hypothesis is the oldest one and 
the neuro-immune hypothesis the youngest. The kindling hypothesis is usually applied to 
explain recurrent mood swings which occur in bipolar disorders. It does, however, also 
elucidate the mechanism of a very powerful treatment of both low and elated mood, 
termed electroconvulsive therapy or ECT.
3At the end of this lecture we hope to have presented you with evidence, making it possible 
to propose the existence of two different, although largely overlapping, components of 
depression. The first component is characterized by the inability to experience pleasure 
and a loss of energy. The second one is accompanied by feelings of misery and negative 
expectations for the future. We think that this last type of depression finds it’s mechanism 
in a dysfunction of structures within the temporal lobe, while the first one finds its 
background in a dysfunction of the brainstem, hypothalamus and extrapyramidal basal 
ganglia.
These two types of depressive symptoms are regulated by two cortical-subcortical-cortical 
circuits. 
The so-called extrapyramidal circuit runs from all neocortical parts of the cerebral cortex 
through the extrapyramidal basal ganglia to new parts of the thalamus and then back to 
the frontal cortex. This circuit regulates movement and motivation. 
The limbic circuit starts in the limbic cerebral cortex, runs through the limbic basal ganglia 
to older parts of the thalamus and back to the limbic frontal cerebral cortex. This circuit 
regulates  reactions to escape from trouble. 
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5We will start with the mono-amine hypothesis of depression, which is, as we have said, the 
oldest of them all. In the 1960s Schildkraut developed the idea that a dysfunction of the 
adrenergic system caused depressive mood disorders and in the 1970s Herman van Praag
added his idea that a malfunctioning of serotonergic neurotransmission was to blame for 
the pathological low mood in depression.
6Two observations are at the basis of this theory. Firstly, reserpine, an antihypertensive and 
antipsychotic drug, which is known to cause a depletion of mono-amine neurotransmitters 
within the brain, causes a severe major depression in a significant number of the patients 
who use this drug. Secondly, all known antidepressant drugs at that time were modifying 
the cerebral levels of the neurotransmitters norepinephrine and serotonin. Tricyclic 
antidepressants inhibit the reuptake of these transmitters from the synaptic cleft and 
monoamine oxidase inhibitors or MAO inhibitors diminish their catabolism. Later it was 
found that the CSF levels of monoamines and their metabolites of depressed patients 
showed important deviations from non-depressed humans. 
Nevertheless, this theory has also important limitations. The effects of antidepressant 
drugs on monoamine levels occur acutely. However, the therapeutic effects of these drugs 
show a lag time of about two weeks. After the development of the receptor binding 
technique in the second half of the 1970s, the existence of this lag time  was explained by 
suggesting that the increased neurotransmitter levels induced a slowly occurring 
adaptation of their receptors. It was found that chronic treatment with antidepressants 
induces a decrease of the sensitivity of 5-HT1A receptors in the hippocampus and an 
increase of beta-receptors in the cerebral cortex.
The essential idea presented in the monoamine hypothesis is that various symptoms of 
depressive disorder are due to a dysfunctioning of three neurotransmitter systems. It says 
that the lack of drive is due to a hypofunction of the adrenergic system using 
norepinephrine is a neurotransmitter. The low mood is due to a hypofunction of the 
serotonergic system, using 5-hydroxytryptamine or 5-HT. The lack of energy is explained by 
a hypofunction of the dopaminergic system. This last system is however only directly 
influenced by nonselective MAO inhibitors and a few other antidepressant drugs.
In order to explain these hypothesis we should depict the basic mechanics of the mind.
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Neurocommunication largely depends on the usage of chemical substances: 
neurotransmitters or neurohormones. Only about 5% of the synapses are electrical in 
nature. The major systems are primarily involved in analysing input and generating output. 
More interesting, for psychopharmacology at least, were the minor systems. These minor 
systems regulate the activity level of the major systems. Interfering with their functioning is 
less detrimental to the functioning of the brain than intervening with for example 
glutamatergic transmission. Hence, such substances have less toxic effects. The cholinergic 
and histaminergic systems regulate the level of awareness. The adrenergic system enables 
the organism to rapidly increase its activity level depending upon the necessities of actual 
circumstances. The dopaminergic system stimulates the organism to maintain a relatively 
high activity level on a substantial longer term. The serotonergic system has opposite 
effects. It mediates relaxation and recuperation.
In simple words:
Norepinephrine: rapid acceleration from 0 to 100 km/hr
Dopamine: finishing the marathon well in time
Serotonine: taking some rest while dozing 
8
Antidepressant drugs interfere with the process of neurotransmission within the synapse. 
Most antidepressant increase the concentration of neurotransmitter in the synaptic cleft by 
inhibiting its reuptake; tricyclic and a few dual action antidepressants of norepinephrine 
and 5-HT, and selective serotonin reuptake inhibitors of only the latter neurotransmitter. 
Bupropion is an example of an antidepressant also inhibiting dopamine reuptake. 
Psychostimulants are release promoters, but these drugs are not really suitable to treat 
depression. An example of an antidepressant which stimulates the release of 
norepinephrine and serotonin is mirtazapine.
MAO inhibitors diminish the oxidative deamination of neurotransmitters after their 
reuptake from the synaptic cleft. More neurotransmitter will be stored within presynaptic 
grana, which means that more substance is released during the next depolarization of the 
terminal. Classical MAO inhibitors like tranylcypromine inhibit the catabolism of both 
norepinephrine, serotonin, and dopamine. The selective MAO-A inhibitor moclobemide
only inhibits the decomposition of the first two neurotransmitters.
9
Norepinephrine was the first neurotransmitter which was thought to be involved in the 
mechanism of action of antidepressants. All cell bodies of this small neurotransmitter 
system are localized within the brain stem. About half of them in the locus coeruleus and 
the rest of them in a set of nuclei that regulate the activity of part of the autonomic 
nervous system. Fibres of the adrenergic neurons run to the diencephalon. These fibres are 
believed to be involved in regulating the emotional and neuro-endocrine responses, 
Another set of fibres run from the brain stem to the cerebral cortex through the medial 
forebrain bundle. According to this heavily simplified model, the fibres running to the 
hypothalamus activate α-adrenoceptors and fibres running to the cerebral cortex β 
receptors. These last projections regulate for example the cognitive response.
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The cell bodies of the serotonergic neurons are also located in the brain stem and as they 
are found in the neighbourhood of the midline (the raphes) these nuclei are termed the 
raphe nuclei. Serotonergic fibres are distributed somewhat more widely than their 
adrenergic equivalents. They run to the spinal cord, several brain stem nuclei, the 
cerebellum, and the diencephalon (hypothalamus). Forebrain structures that are 
innervated by these structures are the basal ganglia, the hippocampus and the cerebral 
cortex.
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In the central nervous system three groups of nuclei can be recognized which contain the 
cell bodies of dopaminergic neurons. Within the caudal part of the medulla oblongata the 
area postrema is situated. Within the most ventral part of the hypothalamus a group of cell 
bodies near the eminentia mediana is found. The most important group of cell bodies 
within the context of this presentation is located in the midbrain. This latter structure 
contains three areas numbered A8, A9 and A10. The latter two correspond to the 
substantia nigra pars compacta (indicated by SNc) and the Ventral Tegmental Area 
(indicated by VTA). From here fibers run to the dorsal and ventral striatum, to the prefrontal 
cortex and to the mesial part of the temporal lobe. Previously, nigrostriatal (dorsal 
striatum), mesolimbic (ventral striatum) and mesocortical (cerebral cortex) projections 
were distinguished, but nowadays these divisions are no longer applied. 
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The central nervous system consists of a spinal cord, brain stem, cerebellum and forebrain. 
This last structure is called cerebrum in Latin and regulates cognitions and emotions. It 
consists of two hemispheres connected with each other and the extensive thalamus. The 
thalamus is a nuclear complex located in the diencephalon and comprising of four parts 
(the hypothalamus, the epithalamus, the ventral or peri-thalamus , and the dorsal or 
proper thalamus). 
Each hemisphere consists of an outer layer of cerebral cortex with a thickness of about 4 
mm and an inner part called the sub-cortex. The cerebral cortex is divided into four parts 
which are named after the skull-bones they adjoin and a fifth lobe; an insula that is on the 
outside covered by the temporal lobe. In humans, about 50 per cent of the cerebral cortex 
is formed by the frontal cortex that in turn consists of three divisions: the motor cortex, the 
dorsolateral prefrontal cortex (in red) and the medial prefrontal cortex (in blue). The insula 
is the smallest part; it covers only about 4 per cent of the cerebral cortex.
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This slide shows you the sub-cortex. The sub-cortex is continuous with the midline 
structures and in that manner connected to the brainstem. It consists of the archicortex
(paleocortex) and the basal ganglia. The basolateral part of amygdala and the hippocampus 
can be considered to be primitive cerebral cortical tissue. The centromedial part of the 
amygdala, the extended amygdala, the striatum and the pallidum (not shown) are the main 
basal ganglia. 
In blue, on this slide, is the striatum which consists of the caudate nucleus, the putamen 
and more ventro-medially of this dorsal striatum; the ventral striatum or Nucleus 
accumbens. This Nucleus accumbens is macroscopically distinguishable in rodents but 
diffusely present in the forebrain of humans. It plays an important role in the regulation of 
motivation and experiencing reward.
14
Also important within the context of this lecture is to remark that the cerebrum can be 
divided functionally into a posterior and anterior half. The input to the brain is received and 
dealt with by the posterior half and the output is generated and released from the anterior 
half. The entire frontal part of the cerebral cortex belongs to the output generating cortex, 
apart from the most posterior part of the orbitofrontal cortex and its boundaries with the 
insula. The hippocampus and the basolateral amygdala can be considered to belong to both 
input and output cortices.
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On this slide the ascending activating systems are shown. Two of those systems are 
distinguished: in the upper brain stem the ascending reticular activating system (ARAS) and 
within the basal forebrain the ascending basal telencephalic system (BTAS). In addition to 
acetylcholine, GABA and hypocretin/orexin, which will not be discussed here, both 
norepinephrine, serotonin, dopamine as well as histamine play an important role in these 
systems. Norepinephrine, dopamine and histamine increase activity, but serotonin has 
generally speaking an inhibitory influence. The two activating systems  are interconnected 
and influenced by the monoamines involved. The ARAS inter alia stimulates the thalamus, a 
structure that can be considered to be the gate to the cerebral cortex. The BTAS stimulates 
the cerebral cortex itself. 
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In its most essential form behavior can be considered to be an adaptive reaction of the 
organism to important stimuli from the environment. Within the brain, input from the 
senses (in man also cognitions)  is transformed into a specific, partly behavioral, output as a 
reaction to the conditions within the individual’s biosphere. 
This process is shown on this slide. Input to the spinal cord and brain stem can result in 
simple reflexes. However, processing the same and other input within the forebrain results 
in far more complex output. Partly this response is involuntary and automatic, partly this 
response is voluntary and carefully planned, and mostly it is a combination of these two. In 
this lecture we call the implicit behavioral response ‘emotional’ and the explicit response 
‘cognitive.’ This is only to give these processes clearly different names.
We apply these two theoretical response types to a simplified situation which could have 
been existing in a very ancient world: a primitive man reacting to a novelty in his biosphere.
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In order to explain the genesis of depression, we want to postulate a model in which man 
has two possibilities to respond to a novel and potentially threatening, or anadvantageous, 
situation: to the right a cognitive and to the left an emotional one. Both result in a suitable 
motor response. When the situation is unclear, and there is no time to analyze all the pros 
and cons of a carefully planned response, an intuitive response is initiated: like ‘duck’ or 
‘run for your life’. In this case, a possible cognitive response is inhibited and priority is given 
to a pre-programmed emotional response. This corresponds to the inhibition of the 
dorsolateral prefrontal cortex and to facilitation of the limbic cortex. 
However, when the situation is clear, e.g. when a predator is watching its game, the 
emotional response is inhibited and all priority is given to the cognitive response. In this 
case, the functioning of the dorsolateral prefrontal cortex is facilitated. 
We hypothesize that the controller of this process of response selection is localized in the 
medial prefrontal cortex. This structure inhibits the amygdala and therewith decreases the 
emotional response.
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Let us first consider the cognitive response type. For the sake of simplicity, we will only 
consider motor output as an example. The desire or urge to generate motor behavior, and 
the plan to realize it, is a function of the prefrontal cortex. The development of a motor 
program and the commanding of the motor pattern generator (MPG) in the brainstem or 
spinal cord is a function of the supplementary motor (SMA), premotor (PMA) and motor 
(MA) cortices. However, this output should also be feedback regulated, dependent upon 
the input from the outer world and the situation within the individual’s body. The gross 
correction of the motor output is taken care of by the cerebellum and the fine tuning is a 
function of a system that we used to call the extrapyramidal system. Actually, a more 
proper name would be the cortico-striato-thalamo-cortical circuit, as we will see 
subsequently. 
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This cortico-striato-thalamo-cortical or CSTC circuit’s primary function is to realize that the 
cortices’ output becomes its own input. Depending upon the activity within this circuit, the 
output of the cortex can be increased or decreased. We will see later on that the activity 
within the circuit is regulated by dopaminergic fibers originating from midbrain nuclei (SNc, 
VTA).
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Actually, the CSTC circuit is not only one single loop, but rather a complete set of parallel 
circuits. These parallel rings can be divided into at least three major sections: 
- A cognitive section in red starting in the parieto-occipito-temporal association cortex 
and running through the caudate nucleus and other basal ganglia to the dorsolateral 
prefrontal cortex.
- A motor section in orange starting in the somato-sensory parietal cortex and running 
through the putamen and other basal ganglia to the motor cortex, and
- A motivational section in purple  starting in archi- and mesocortical limbic areas and 
running through the accumbens nucleus and other basal ganglia to the medial prefrontal 
cortex.
This figure is not entirely correct. The figure is only shows the posterior part of the circuits. 
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Actually, within every circuit information from different anterior and posterior parts of the 
cerebral cortex converges to a specific point of the frontal cortex. This also results in a few 
re-entry circuits within the prefrontal cortex, where the respective CSTC circuit both starts 
and ends. We will come back to this later.
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The most ventral CSTC circuit runs through the Nucleus accumbens. This circuit regulates 
the intensity of the desire or urge to generate specific motor behavior. The nucleus 
accumbens has two parts. The core part regulates the motivation to exhibit ‘cognitive’ type 
behavior that will finally result in a reward feeling. This core part receives input from the 
anterior cingulate cortex and the orbitofrontal cortex.  The shell part regulates ‘emotional’ 
type behavior of which the outcome is uncertain. The shell part receives also input from 
the orbitofrontal cortex, but additionally from the infralimbic cortex. The infralimbic cortex 
is situated below the genu part of the Corpus callosum on the mesial side of the prefrontal 
cortex. It is also called Subgenual Anterior Cingulate Cortex or Brodmann area 25.
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Now we return to this slide. When man is confronted with novel, uncertain information, 
which possibly indicates a threat, the shell part of the Nucleus Accumbens stimulates 
defensive, fight or flight behavior. When man is confronted with novel information,  that is 
probably indicating possible reward, the core part of the Nucleus accumbens stimulates 
cognitive, catch as you can, behavior.
Let us now consider how the emotional fight or flight response is regulated, because this 
differs from the regulation of a planned motor response.
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At this point of our lecture we can  introduce the ideas of Terence and Mark Sewards
(2003) about how the central nervous system regulates certain vital emotions like sexual 
desire, hunger, thirst, and fear. They describe how the medial and preoptic areas of the 
hypothalamus play a central role as a controller of these emotional behaviors. Every 
regulatory scheme consists of three different components. 
- Firstly, the hypothalamus influences the periaqueductal grey and thereafter other brain 
stem structures. This activation results in the initiation of the autonomic component of the 
emotional response. Moreover, the cerebral cortex is influences by e.g. adrenergic and 
serotonergic projections from the brainstem. 
- Secondly, the medial part of the hypothalamus also influences the lateral endocrine part 
of this diencephalic structure. This results in the endocrine component of the emotional 
response. 
- The third component is activated by fibers running from the medial hypothalamus to 
midline and intralaminar nuclei of the thalamus. This results in the motor component of 
the emotional response (e.g. the startle reaction). Moreover the thalamus influences the 
dorsolateral prefrontal cortex in order to stop the cognitive plans that were currently in 
progress. Finally, parts of the mesial prefrontal cortex is activated which results in a drive to 
respond.
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For some of the emotional response types the amygdala serves as the initiator. This is for 
example the case in initiating the fear and the anger scheme. The amygdala receives 
information directly from the posterior cortex, from the hippocampal complex and from 
the medial prefrontal cortex. This last structure mainly inhibits the amygdala’s activity.
The model of Sewards and Sewards (2003) describes the hypothalamus as a structure that 
controls the proper execution of the different emotional response types. In this model the 
hypothalamus contains a set of predefined schedules that only have to be executed when 
activated upon proper grounds. At least for the flight and fight reactions these proper 
grounds are determined by the amygdala. 
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The amygdala may be the most important structure to initiate the considered emotional 
response types, but does not stands on its own in sustaining these anger/rage or 
anxiety/fear emotional reaction types. 
The amygdala is a complex of nuclei in the pole of temporal lobe that consists of two 
divisions with a different embryological origin. The basolateral part has a cortical structure 
and serves as an input channel. This part inter alia receives information from the mesial 
temporal complex (the hippocampal complex) and from the medial prefrontal cortex. The 
centromedial part has a basal ganglionic structure and serves as an output channel. This 
part inter alia gives rise of signals to the hypothalamus.
The basolateral part of the amygdala can be considered to belong to the limbic cortical 
areas. It plays an important role in deciding which reaction type should be exhibited. The 
centromedial part of the amygdala can be considered to belong to the limbic basal ganglia 
(colored orange in this figure), together with the extended amygdala, the bed nucleus of 
the stria terminalis and the shell part of the Nucleus accumbens. These ganglionic 
structures play an important role in facilitating these emotional reaction types.
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This brings us back to this figure. The centromedial amygdala belongs to the limbic basal 
ganglia as is the shell part of the Nucleus accumbens. As was discussed before the nucleus 
accumbens acts as an interface between the limbic and motor systems and facilitates 
either the automatic emotional or more the planned motor response. What is also shown 
in this figure is that both parts of the accumbens receive dopaminergic fibers from the blue 
VTA, the ventral tegmental area, in the midbrain. It is only the shell part of the Nucleus 
accumbens which also receives norepinephrine containing fibers coming from the 
adrenergic locus coeruleus in the hindbrain. So dopamine stimulates both emotional and 
planned response types and norepinephrine primarily the emotional response. 
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The foregoing explanations are integrated in this figure, which we have already shown at 
the beginning of this lecture. In this figure we distinguish two cortico-ganglio-thalamo-
cortical circuits. In blue the extrapyramidal circuit is shown, regulating the activity of newer 
parts of the frontal cortex.  This circuit facilitates motor behavior that finally leads to 
improvement of the individual’s situation and what is related to reward feelings. Within this 
circuit two re-entry rings can be distinguished starting and ending within the orbitofrontal 
cortex (OFC) and anterior cingulate cortex (ACC). 
In orange the limbic circuit is shown. This circuit regulates the activity of phylo-genetically  
older parts of the frontal cortex.  This loop facilitates behavior which finally results in the 
escape from threats to the individual’s wellbeing. The two re-entry rings which belong to 
this limbic circuit start and end in the orbitofrontal cortex (OFC) and the subgenual anterior 
cingulate or infralimbic cortex (sCg). 
These two circuits are neither functioning independently from one another nor from the 
rest of the forebrain. Sensory input to the posterior part of the cerebral cortex is conveyed 
stepwise to more anterior sites of the cerebral cortex and simultaneously to corresponding 
parts of the basal ganglia. This results in a well integrated activation pattern of both the 
frontal cortex and the relevant cortical-subcortical circuits.
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The activity of the cortical-subcortical circuits is also affected by serotonergic neurons, but 
their influence is largely an indirect one. Inhibitory GABA-ergic interneurons are stimulated 
by serotonin binding to serotonin type 2 receptors. These GABA-ergic interneurons inhibit 
cell bodies of dopaminergic neurons in the midbrain and nerve terminals within the 
forebrain. A similar relationship is found with adrenergic neurons of the locus coeruleus
and adrenergic terminals within the forebrain. So, serotonin inhibits the release of 
dopamine and norepinephrine. This partly explains serotonin’s relaxing and recovery 
promoting influence.
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However, serotonin has also another influence; it affects the functioning of the 
hippocampus and amygdala. The amygdala receives input from different parts of the 
cerebral cortex, including the sensory association cortex and the parahippocampal region. 
The hippocampal complex plays an important role as a controller of declarative memory 
formation. Within the hippocampal region sensory information is identified as either having 
occurred before or as being new and unexpected. Therefore, the hippocampus is 
considered to be the controller of the memorization process. Moreover, the hippocampal 
complex has an important influence on the amygdala. The initiation of an emotional 
response is either facilitated (warning: unidentified, potential harmful situation) or 
inhibited (relieve: innocent object, no thread). When a potential harmful object is 
identified, also inhibition of the emotional response can occur and facilitation of a cognitive 
defense reaction may follow, the hippocampal complex gives output to different parts of 
the (pre)frontal cortex. a chronic dysfunction of the hippocampus may result in a chronic 
state of hyperarousal and fear. 
Serotonin has complex effects on the functioning of the hippocampus. 
31
Serotonin has complex effects on the functioning of the hippocampus: it prevents 
dysfunctioning of the hippocampus by directly stimulating serotonin type 1A receptors and 
it inhibits the effects of glucocorticoid receptors. These glucocorticoid receptors induce 
hypoplasia of the hippocampus and SSRIs are known to protect the hippocampal neurons 
against this influence. It is possible that these two effects are strongly interrelated. 
However, also other biological responses may also result from the stimulation of serotonin 
type 1A receptors.
As a consequence, according to this model, serotonin promotes adequate functioning, or it 
relieves inadequate functioning, of the hippocampal complex. Such an effect would result 
in an inhibition of the amygdala to induce an inadequate emotional response. As a result of 
such an action, the cognitive response gets a proper chance to take over. This would result 
in a relief of the emotional disorder, whether it is a mood disorder or an anxiety disorder. 
Such a mechanism would correlate with the high efficacy of SSRIs in combination with 
cognitive behavioral therapy (CBT). SSRIs facilitate the possibility of the prefrontal cortex to 
adopt cognitive schemes that limit the stressful depressive response.
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The two described circuits also correspond to two different feelings: pleasure and 
happiness. 
High activity of the motivational ventral striatal circuit results in a strong urge to exhibit 
reward seeking behavior. This urge corresponds to a feeling of craving for obtaining the 
effects of illicit drugs. The sudden relief from this urge results in experiencing pleasure.
High activity of the emotional ventral striatal circuit results in a strong urge to escape from 
this threat to the individual’s well being. This urge corresponds to a feeling of dysphoria. 
The sudden relief from this urge results in a feeling of happiness.
33
Although the exact mechanism has not been elucidated, it is clear that depression is 
accompanied by a dysfunction of the prefrontal cortex. 
Resting-state PET and SPECT studies in patients with primary depression consistently show 
a decreased frontal lobe function. The anatomical localization involves both the 
dorsolateral prefrontal cortex (Brodmann’s areas 9, 10 and 46) and the ventral prefrontal 
and orbitofrontal cortices (Brodmann’s areas 10, 11, and 47). Hypoactivity in the 
dorsolateral areas may correspond to apathy and cognitive dysfunctioning. 
A third prefrontal structure that has been implicated in negative mood states is the 
subgenual part of the anterior cingulate cortex (Brodmann’s areas 25 and the caudal 
portions of Brodmann’s areas 32 and 24). Anatomical studies have shown that the volume 
of the sCg is reduced in certain depressed groups. Moreover, the activity of the sCg is 
affected following successful treatment with SSRIs, electroconvulsive therapy, transcranial
magnetic stimulation (rTMS), ablative surgery and deep brain stimulation. However, this 
sCg has been found to be metabolically overactive in depressed states and reacts to 
treatment with a decrease of its activity. 
These findings indicate, that in depression two processes contribute to pathophysiology. 
Firstly, the previously described hypofrontality corresponds to lack of motivation to exhibit 
rewarding behavior. This is accompanied by the inability to experience pleasure. Secondly, 
the hyperfunction of the subgenual anterior cingulate corresponds to an increaded
motivation to escape from threats to well being. This is accompanied by feelings of 
dysphoria, which is the opposite of happiness.
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This slide summarizes how the adrenergic, serotonergic, and dopaminergic systems affect 
the functioning of the forebrain. As shown, serotonin inhibits the adrenergic and 
dopaminergic systems and in addition stimulates the functioning of the hippocampus. This 
brings us to the essentials of the amine hypothesis of depression.
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Antidepressant drugs can  influence depressive disorder because they stimulate adrenergic 
neurotransmission within the hypothalamus and/or serotonergic neurotransmission within 
the hippocampus. Some of them also influence dopaminergic transmission which results in 
stimulation of certain parts of the prefrontal cortex. The lag time between the 
pharmacological and clinical effects is caused by the time it takes for the changes in 
functioning become effective. It should be considered that the adrenergic, serotonergic and 
dopaminergic systems are heavily interconnected. It is not possible to influence one system 
without affecting the other.
36
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Mood disorders can also be considered as biorhythm disorders. This brings us to the 
second theory of the genesis of mood disorders.
Several aspects of the symptomatology of depression indicate that something is wrong 
with the biological clock. Depressive disorders are well known to be accompanied by sleep 
disturbances. In patients with a depressive disorder the time period between the moment 
they fall asleep and the moment that the first REM sleep occurs, is remarkably shorter than 
in non-depressed humans. In some individuals REM sleep even occurs instantaneously. This 
is reflected by an astonishing distortion of the sleep architecture, i.e. the sequence of sleep 
stages during the night. Moreover, depressed patients suffer from an interrupted sleep and 
late night insomnia. Apart from these sleep disturbances other biorhythm disorders are 
evident. In depressed patients mood and other symptoms show a typical fluctuation of 
severity during the day. In the morning they feel worse and during the course of the day 
things go slightly better. Also other biorhythms, such as body temperature and the cortisol 
rhythm, become irregular. 
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The sleep disorders can be illustrated by comparing a hypnogram of a depressed patient 
before and after treatment with ECT. A hypnogram is a graphic representation of the sleep 
stages that occur during sleep. It is based upon the EEG activity that is exhibited by the 
sleeping brain. After falling asleep a person’s sleep initially becomes deeper and deeper. 
After having spent a period in sleep phase IV (deep sleep or slow wave sleep), sleep 
becomes lighter again and a period of paradoxal sleep or REM sleep follows. In normal 
adults, it takes about 1.5 hours to pass through such a sleep cycle. During the night several 
sleep cycles are passed through. The hypnogram of a depressed patient is entirely different. 
The sleep phases are irregularly distributed. In this patient, the first REM sleep phase 
occurs rather late, but that is not typical. What is evident is that the sequence of sleep 
phases is abnormal. After recovery, a normal hypnogram is observed.
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This figure shows the relevant biorhythms during night (in blue) and day (in white). Two 
rhythms determine the alternating sequence of wakefulness and sleep: i.e. the circadian 
biorhythm and the somnostatic rhythm. The fluctuations in body temperature and that in 
ACTH and renin secretion are intricately connected to the circadian biorhythm. Other 
fluctuations are less clearly linked to the circadian bio-clock. It is hypothesized that a 
theoretical sleep factor S is built up, when a person is awake. When a person is active 
during the day the need to fall asleep is steadily increases. During the night when a person 
is sleeping the amount of this theoretical sleep factor S decreases. The person will wake up 
when sleep factor S has disappeared to a large extent and simultaneously the circadian 
rhythm is in a correct phase.
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The circadian rhythm is caused by a rhythmic fluctuation of the membrane potential of 
neurons in the suprachiasmatic nucleus in the hypothalamus. These neurons secrete 
vasopressin (ADH) from fibres which run to the paraventricular nucleus. This secretion also 
shows rhythmic fluctuations. Fibers from the paraventricular nucleus release CRH into the 
primary portal circulation of the pituitary gland. This explains the rhythmic fluctuation of 
ACTH secretion. 
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The genuine circadian biorhythm is established somewhat beyond 24 hours. Therefore, the 
awakening can become an important ‘Zeitgeber’ that will reset the circadian rhythm, This 
daily occurring process is termed ‘entraining.’ Several other Zeitgebers are active apart 
from this awakening stimulus, though far less important then awakening. One of them is 
the hourly pulses with which corticosteroids are secreted from the adrenal glands.
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Daylight plays the most important role in the entraining process. Although highly simplified 
and not entirely correct, this can be explained by the following model. Awakening is 
thought to reset the biological clock of the nucleus suprachiasmaticus (SNC) by full 
exposure to daylight when the eyes are opened and daytime activity starts. The SNC is 
directly connected to the retina by fibers that deviate from the optic tract before reaching 
the thalamus and the cerebral cortex. Therefore, this mechanism is also functioning in 
cortical blindness, but not in retinal blindness. The sensitivity for the entraining influence of 
daylight on both the retina and the SNC is enhanced by melatonin. Melatonin is a hormone 
that is secreted by the pineal gland during sleep provided that this sleep matches with the 
night phase of the circadian rhythm. The secretion of melatonin is initiated by fibers of a 
branch of the sympathetic nervous system running from the superior cervical ganglion to 
the pineal gland. Melatonin binds to specific receptors in the SNC (Mel-1a) and retina (Mel-
1b), This explains why treatment with an evening dose of melatonin has therapeutic effects 
on the biorhythm in patients with a dysfunctioning retina (e.g. retinal blind people). 
Melatonin increases the entraining influence on the SCN of the first stimulation by daylight 
at awakening. 
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The biorhythm hypothesis of depression postulates that the depressive symptoms are 
caused by a dysfunction of the SNC as the generator of a correct circadian rhythm. One 
hypothesis says that in depression there is a mismatch between the biological rhythm and 
the true natural rhythm. When the biological rhythm is shorter than 24 hours this 
mismatch would cause a false start. It is possible that this would cause serious trouble. 
However, experiments have given contradictory results. Another hypothesis says that in at 
least some depressed patients an entraining disorder is causing the problems. This may be 
due to insufficient influence of day light as a ‘Zeitgeber’. In turn this may be related to 
insufficient stimulation of the retina by daylight or to insufficient sensitivity of the SNC or 
both. In a subpopulation of depressed patients exposure to bright light has therapeutic 
effects as well as treatment with an evening dose of melatonin. However, in many 
depressed patients this is not the case. Therefore, it is not very likely that this mechanism is 
the primary defect and that depression is comparable with a sort of exaggerated 
hibernation state in humans. However, it can be suggested that in a subpopulation of 
patients this mechanism may play a role by inducing neuro-endocrine disturbances that are 
related to the pathogenesis of depression. This links the biorhythm hypothesis to the …
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… neuro-endocrine hypothesis of the depressive disorder.
The neuro-endocrine hypothesis of depressive disorder says that the mood disorder results 
from a dysregulation of the endocine system. 
At least three endocrine sub systems have been postulated to be candidates for playing an 
important role in the pathogenesis of depressive disorders. Improper functioning of the 
thyroid gland and of the endocrine gonads is well known to accompany a variety of mood 
disturbances. Although this is certainly relevant, it will not be discussed here in further 
detail. 
In this lecture we will concentrate on the HPA axis. Several HPA abnormalities are observed 
in mood disorders, although they are not always consistently found and seem to be 
variable in different subgroups of depressed patients. Increased plasma levels of 
corticosteroids are observed in a large proportion of these patients. In addition, several 
depressed patients do not respond with the same increase of cortisol levels after the 
administration of the Corticotrophin Releasing Hormone (CRH). The circadian cortisol 
rhythm is lost and an exogenous corticosteroid dexamethason is not as active in inhibiting 
cortisol secretion as in non-depressed persons. These findings indicate that HPA axis is 
hyperactive and less sensitive to feedback inhibition in patients with a major depression. 
These changes are nowadays believed to be orchestrated by CRH. It has been 
demonstrated that the abnormality is already present at the level of the hypothalamus. A 
hyperplasia is observed in the hypothalamus of paraventricular cells that secrete CRH into 
the primary portal circulation of the pituitary gland. In reaction, this gland produces more 
ACTH which stimulates the adrenal glands.
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This sequence is shown in the current slide; hypothalamic paraventricular cells produce 
CRH which stimulates the pituitary gland to produce ACTH. This hormone stimulates the 
cortex of the suprarenal glands to secrete cortisol into the general circulation. Cortisol 
inhibits the hypothalamus and the pituitary gland to secrete CRH and respectively ACTH 
and therefore gives feedback inhibition. This last process appears to be disrupted in 
depression. 
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Cortisol is secreted from the adrenal glands in hourly pulses, with the largest pulse 
amplitude at the start of the circadian activity period. Cortisol can penetrate into the brain 
and has multiple effects depending on its levels. This is due to the presence of two types of 
cortisol receptors, called mineralocorticoid receptors (MR) and glucocorticoid receptors 
(GR). These names are not entirely correct because the mineralocorticoid aldosterone 
poorly penetrates into the brain and therefore does not bind to these MR receptors itself; 
both receptor types are cortisol (a glucocorticoid) receptors. MR as well as GR receptors 
are ligand-driven transcription factors functioning in genomic control, acting within the cell 
nucleus. They are therefore called nuclear receptors. However, within the brain, 
membrane associated mineralocorticoid receptors are also found. Cortisol has low affinity 
to these membrane bound mineralocorticoid receptors, so these are only activated by the 
high levels of cortisol occurring during a stress reaction.
As can be seen on this slide the different cortisol receptors have different functions. 
Nuclear mineralocorticoid receptors induce tonic inhibition and stabilization of cerebral 
neurons, while membrane bound mineralocorticoid receptors increase excitability. Nuclear 
glucocorticoid receptors have the important function of facilitating the return to a normal 
situation once a stress response has taken place.
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The described effects (also) take place in the hippocampus. At low concentrations cortisol 
stimulates mineralocorticoid receptors which are situated within the cell nucleus. By 
stimulating these mineralocorticoid receptors cortisol induces recovery and repair and it 
prepares the hippocampus to give an adequate and rapid response to a stressful situation. 
At high levels, cortisol is bound to nuclear glucocorticoid receptors. These receptors modify 
the stress response and thereby optimize this stress reaction. High concentrations of 
cortisol normalize brain activity some hours after an organism has been exposed to a 
stressful event and promote consolidation of the event for future use. At the same time 
high concentrations of cortisol also stimulate low affinity mineralocorticoid receptors which 
are located in the outer cell membrane. These high levels of cortisol activate the 
hippocampus to immediately participate in the stress response. In response to this 
stimulation the hippocampus starts sending signals to other areas including the amygdala 
and prefrontal cortex. So, high levels of cortisol acutely facilitate the emotional response 
type and inhibit the cognitive response type. In addition, through stimulation of nuclear 
glucocorticoid receptors  high levels of cortisol simultaneously protect hippocampal cells 
against possible damage by uncontrolled, heavy activity and limit the stress response on a 
somewhat longer term.
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In patients with a depressive disorder a change in the functioning of this mechanism is 
observed. This has been explained by the Dutch scientist Ron de Kloet by postulating that 
- sustained hyperactivity of the HPA-axis on the one hand
- in addition to a MR/GR imbalance which is precipated by (early) life stress on the other, 
may generate a phenotype that is vulnerable for depression. 
So, the pathological changes in depression are thought to be caused by an imbalance 
between the functioning of MR and GR receptors in the hippocampus. 
As a consequence of this hypoplasia of the hippocampus occurs, which may reflect a 
dysfunction of this structure. 
As has been said before, the hippocampus is important for the functioning of the 
declarative memory. When the hippocampus stops identifying objects and events, the 
emotional response type will dominate the picture. This results in constant activation of 
the limbic cortico-ganglio-thalamo-cortical circuit in order to escape from this misery. 
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A few experimental findings indicate that the antidepressive effects of drugs, particularly 
SSRIs, have something to do with the effects of cortisol on the hippocampus. It has been 
found that stimulation of 5-HT1a receptors protects the hippocampus against cortisol-
induced dysfunction as well as cortisol-induced hypoplasia. Through (chronic) stimulation 
of these 5-HT1a receptors, SSRIs seem capable of repairing the MR/GR imbalance. This 
results in a proper inhibition of the amygdala by sensory information that makes the actual 
situation harmless and unthreatening and placing the individual at ease again.
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This brings us back to this slide, which we have seen before when we were dealing with the 
role of serotonin. The amygdala gives a signal to the hypothalamus to start or increase an 
emotional fear/flight or anger/fight reaction on the basis of the input of sensory 
information to the basolateral part of this complex. This process is facilitated or inhibited 
by information coming from the hippocampus. The hippocampus is the controller of the 
identification and memorization process (episodic memory). After identification it gives an 
inhibitory signal to the amygdala and a stimulatory signal to the prefrontal cortex to plan 
and execute an adequate cognitively planned response. When the hippocampus 
dysfunctions due to neuroplastic changes which are induced by cortisol, the amygdala is 
disinhibited and keeps on activating the emotional reaction type.
Note:
Apart from this mechanism chronic stress also induces direct neuroplastic changes in the 
medial prefrontal cortex and in the amygdala. We will return to this phenomenon later.
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So, when we summarize the neuro-endocrine hypothesis of depression: In depressed 
patients problems are caused by the existence of a disturbed balance between 
mineralocorticoid and glucocorticoid receptors which results in a malfunctioning of the 
hippocampal complex. This leads to inadequacies regarding the recognition of episodic 
memories. As a consequence the amygdala is too often or too strongly activated to initiate 
an emotional fear/flight response.
The malfunctioning of the hippocampus is largely based on inadequate neuroplastic effects 
of cortisol. Cortisol has profound neurotrophic activity and it shares this capacity with the 
so-called cytokines which are produced by immune-competent cells. In addition, the 
functioning of the HPA axis and the immune system are intricately interconnected. This 
brings us to the description of the related …
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… neuro-immune hypothesis of depression.
Essential to the neuro-immune hypothesis is the observation that the immune system is 
intricately connected to the functioning of the central nervous system. This is partly 
mediated by the interaction between the HPA axis and the immune system, partly by a 
direct interaction between neurons and immune cells. 
This complicated interaction between nerve cells, endocrine cells and immune cells is 
regulated by chemical substances. We have already dealt with neurotransmitters secreted 
by neurons and hormones secreted by endocrine cells, but until now did not mention 
cytokines; the substances which transfer the messages of immune cells. Similar to cortisol 
many cytokines exert neuroplastic effects, which make them special type neurotrophic 
factors. Similar to other neurotrophic factors they exert a profound action on the 
functioning of nerve cells. Neurotrophic factors are known to enhance or limit the 
sprouting of axons and dendrites and the formation of new branches and projections. 
Moreover, when one nerve cells makes contact with another neuron, the influence of 
specific neurotrophic factors modifies the contact spot into a regular synapse and regulates 
its activity.  So, neurotrophic factors change the structure of the central nervous system on 
a micro scale and cytokines may be an example of substances having this type of effect.
So, an important category of neurotrophic alterations is primarily associated with the 
functioning of the immune system. And in depression the immune system appears not to 
function properly. This is reflected by the changes in the blood levels of many pro-
inflammatory and anti-inflammatory cytokines. Through these changes depression leads to 
structural changes which can be considered to be neurodegenerative in nature. This is 
accomplished directly by neuroplastic effects of cytokines, by inducing the synthesis of 
neurotoxic substances and by affecting the influence of the HPA hormones.
Concerning this influence of the HPA hormones, we should consider that several lines of 
evidence suggest that cytokines may contribute directly to insufficient glucocorticoid 
signaling by diminishing glucocorticoid receptor activity. Administration of cytokines in vivo 
and in vitro has been shown to reduce both glucocorticoid receptor number and function. 
These findings may provide a plausible scenario in which glucocorticoid insufficiency 
contributes to unrestrained cytokine release, which in turn further impairs glucocorticoid 
receptor functioning. 
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As is shown on this slide, the functioning of the HPA axis and the immune system are 
mutually dependent upon each other. As was explained a few slides back, cortisol inhibits 
the hypothalamus in producing CRH and the pituitary gland in producing ACTH. On the 
other hand, cortisol reacts with intracellular receptors in peripheral immune cells. These 
complexes translocate to the nucleus and inhibit the immune response either by 
interacting with other transcription factors or by directly binding to DNA to influence gene 
transcription. The first results in abolishing the production of cytokines and the second in 
the production of inhibitors that work as an anti-inflammatory factor. So, cortisol inhibits 
both the HPA axis and the immune response.
On the other hand, certain pro-inflammatory cytokines, such as interleukin (IL)-1, 
interleukin (IL)-6 and tumor necrosis factor (TNF)-α, are potent stimulators of CRH release 
and therefore of the HPA axis. These pro-inflammatory cytokines are produced in the 
periphery by a variety of immune cells, in response to different stimuli including danger 
signals and stress. The stimulation of the HPA axis which results from this release limits the 
activation of the immune response when the danger is eliminated. It has been postulated 
that aberrant activation of CRH pathways by pro-inflammatory cytokines is at the basis of 
the over activity of the HPA axis in depression. It therefore represents one of the primary 
mechanisms by which cytokines contribute to the development of HPA hyperactivity in 
depression. 
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Now, let us summarize this complex matter. Essential to the neuro-immune hypothesis is 
the observation that the immune system is intricately connected to the functioning of the 
central nervous system. In addition, the HPA axis and the immune system mutually 
influence each other. These interactions, and the aberrant alterations of them that occur in 
depressed patients, induce a chronic inflammatory condition of the central nervous system 
in depression. This leads in turn to structural changes that can be considered to be 
neurodegenerative in nature and can progress into Alzheimer’s disease and other 
dementias. Antidepressant drugs may protect neurons from these changes by promoting 
repair and the construction or reconstruction of neuronal networks.
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Cytokines have important effects in the central nervous system. Peripheral immune 
activation is transmitted to the brain by several communication pathways that include 
saturable transporters of cytokines across the blood-brain barrier, humoral transmission via 
the circumventricular organs, and neural transmission via afferent nerves, for example the 
vagal nerve, that innervate the site of the body in which the inflammatory response takes 
place. This ultimately results in the synthesis and release of pro-inflammatory cytokines in 
the brain by activated astrocytes, microglia cells, vascular endothelial cells, and fibroblasts. 
Moreover, during the last three decades it has become evident that the central nervous 
system also contains its own immune system. This CNS immune system is actively involved 
in stress reactions. It also has become clear that an important interaction exists between 
the CNS and peripheral immune systems on the one hand and between both immune 
systems and other CNS regulatory systems on the other.
Cytokine receptors are present in the brain, but they are activated in most cases not by 
peripheral cytokines that enter the brain, but by cytokines that are produced locally within 
the brain in response to peripheral cytokines. These locally produced cytokines act on 
other glial cells and ultimately on neurons. 
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Cytokines form an important link between the immune system and mental functioning. On 
the one hand, the peripheral cytokine production is influenced by mental processes, either 
directly (e.g. resulting from an increase of the sympathetic tone) or indirectly through 
activation of the HPA axis. On the other hand, brain cytokines activate the HPA axis and the 
neural circuits involved in the regulation of sleep, appetite, metabolism, affect, and 
cognition. Via their actions in the brain, cytokines are responsible for the occurrence of the 
non-specific symptoms of sickness, including apathy, social withdrawal, anhedonia, fatigue, 
and alterations in cognition and mood.
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The complex relationship between stress and cytokines or glucocorticosteroids is 
summarized in this figure. Stress results in a direct activation of the peripheral immune 
system on one hand and in a somewhat slower occurring inhibition of the same peripheral 
immune response by activation of the HPA axis and the sympathetic nervous system on the 
other hand. Pro-inflammatory cytokines activate the release of brain cytokines, and these 
activate relevant neuronal circuits but also the HPA axis. Glucocorticoids inhibit the release 
or function of these pro-inflammatory cytokines and also induce feedback inhibition of the 
activity or the HPA axis. When this system cooperates correctly the source of stress is dealt 
with correctly by a self-limiting mechanism.
Depressed patients show elevated levels of corticotropin-releasing hormone. It is a key 
neuropeptide in the regulation of the response to stress, orchestrating stress-induced 
activation of the HPA axis (and the release of adrenocorticotropic hormone and cortisol) 
and the sympathetic nervous system (and the release of catecholamines). Activation of 
corticotropin-releasing hormone pathways by pro-inflammatory cytokines represents one 
of the primary mechanisms by which cytokines may contribute to the development of 
depression. 
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Serotonin can be considered to offer protection against the damaging influence of the 
inflammatory process during depression. Serotonin appears to be of huge importance for 
normal CNS development and function. Serotonin acts as a growth factor during 
embryogenesis, and serotonin receptor activity forms a crucial part of the cascade of 
events leading to changes in brain structure. The serotonergic system interacts with brain-
derived neurotrophic factor (BDNF). This may explain why antidepressant drugs increase 
the signaling of BDNF. It has been suggested that the chronic effects of antidepressant 
drugs are associated with the repair, and possible construction, of neuronal networks. 
Antidepressants are known to enhance axonal and dendritical sprouting and are believed to 
stabilize synaptic contacts.
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The neuro-immune hypothesis on the pathogenesis of depression has not yet found its 
definite form. Several possibilities exist to show how activation of the CNS immune system 
results in a change of functioning of the central nervous system. We try to explain the 
genesis of a depressive disorder by concentrating on an inhibition of the functioning of the 
hippocampus. This may result in an improper stimulation or a disinhibition of the amygdala. 
Moreover, cytokines have a profound influence on the excitability of neurons. When this 
phenomenon occurs in the amygdala and is added to an decreased inhibitory input from 
the hippocampus, a phenomenon termed ‘kindling’ may occur. This brings us to the last 
hypothesis for the pathogenesis of the depressive disorder.
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The illness progression hypothesis is most often referred to as the ‘kindling’ hypothesis. 
This theory says that, analogous to the relationship between kindling and convulsions, 
some stressors may produce increasing effects over time resulting in a full-blown affective 
episodes. The more episodes of unipolar or bipolar illness a patient has, the more 
vulnerable he or she becomes to recurrences and the development of cognitive 
dysfunction. In the current lecture, we want to take this idea a step beyond this point to a 
possible explanation for the pathogenesis of depression. But let us first explain the original 
theory.
Kindling is an electrophysiological phenomenon that occurs in the pharmacological 
laboratory when cortical areas  of animals are daily stimulated with weak electrical stimuli. 
These stimuli are usually applied for 1 second per day to limbic areas such as the amygdala 
or the hippocampus and are subluminal which means that they are below the threshold to 
induce a response. However, when applied on a daily basis to the same area, they are able 
to activate the cortex. This first starts to result in the occurrence of after-discharges that 
gradually increase in duration and complexity and start to spread around through the 
cortical surroundings. If this stimulation is continued, full-blown motor seizures start to 
occur and thereafter also start to occur spontaneously in the absence of exogenous 
electrical stimulation. 
The kindling model is used both in studies on the development of some kind of clinical 
seizure disorders (e.g. temporal lobe epilepsy) and on the genesis of certain behavioral 
disorders (particularly bipolar mood disorders). We think a similar phenomenon occurs in 
the affective disorder where initial episodes are triggered by psychosocial stressors, but, 
with enough repetition, they also begin to emerge spontaneously.
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Amygdala-kindling is accompanied by several biochemical changes involving classical 
neurotransmitters, neuropeptides, cytokines and neurotrophic factors. Some of these 
changes are believed to represent the pathophysiological process that is at the basis of the 
evolution of seizures. These are shown on a time axis in the upper figure of this slide. 
Others alterations are thought to reflect adaptative and compensatory changes that result 
in a transient anticonvulsant effect.  These are shown in the lower figure. These last 
changes consist of an induction or increased expression of thyrotropin-releasing hormone 
(TRH), cholecystokinin (CCK), neuropeptide Y (NPY) and Benzodiazepine/GABA receptors. 
A key finding, which possibly links kindling with the neuro-endocrine hypothesis, is the 
observation that the expression of corticotropin-releasing hormone (CRH) plays an 
important role in the evolution of kindled seizures. As we have seen, CRH is an excitatory 
transmitter that operates as the cardinal central nervous system transducer of stressful 
stimuli. Neurons that synthesize CRH or possess CRH receptors are abundantly present in 
the amygdala and hippocampus. Repeated stimulation of these receptors is known to result 
in limbic seizures. Moreover, corticosteroids are known to facilitate epileptic convulsions 
induced by electrical amygdala kindling. So, both neuronal (CRH) and humeral (steroid) 
factors link the endocrine HPA system to facilitation of kindling of the amygdala induced by 
repeated and similar stress stimuli.
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Difficult to understand, but therefore perhaps even more intriguing, is the influence of 
cytokines and neurotrophic factors on the kindling process. (And then, let us not even not 
consider the complex interactions among them). Their effects are often found to be 
biphasic and/or very complex in nature. This is true for the most studied cytokines (IL-6, 
TNF-α, and IL-1β) as well as, for example, for brain derived neurotrophic factor (BDNF). 
IL-6, for example, increases the vulnerability to excitotoxicity by glutamate (causing cell 
death), but is also involved in neuroprotection against cell death. The same is true for TNF-
α and IL-1β. Also BDNF increases neuronal excitability and at the same time seems to have 
neuroprotective effects. 
BDNF is a very important neurotrophic factor which probably plays an important role in 
both the genetic and environmentally induced vulnerability to the development of a 
(bipolar) mood disorder. Insufficient protection from the kindling phenomena by a fall of 
BDNF is believed to induce the development of an affective episode. The serotonergic 
system interacts with brain-derived neurotrophic factor (BDNF). This may explain why 
selective serotonin reuptake inhibitors increase the signaling of BDNF. This may be the 
pharmacological basis for the prophylactic activity of SSRIs in preventing recurrences of a 
depressive episode.
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Let us return to the kindling hypothesis. A few findings link this kindling hypothesis to our 
ideas about the pathogenesis of depression. Both corticosteroids and CRH are known to 
enhance the excitability of cortical neurons of the basolateral amygdala. This results in a 
lowering of the stimulation threshold of this cortical structure. So, repeated and malicious 
activation of the HPA axis may be able to induce uncoordinated electrical activity within the 
limbic cortex, which will finally result in hyperactivity of the limbic cortico-ganglio-thalamo-
cortical circuit. The vulnerability for kindling of the amygdala is decreased by BDNF. The 
opposite may be true for other neurotrophic factors and cytokines. So repeated stress 
reactions may induce hypersensitivity to activate emotional fear/flight reactions . 
Although hard evidence supporting this hypothesis is lacking, the kindling theory certainly 
offers one of the best explanations for illness progression in affective disease. However, it 
does not explain why some persons develop an affective illness and others not. Repeatedly 
occurring psychosocial stressful events are considered to be an ordinary aspect of life. In a 
normal situation, the organism is supposed to be well capable of adequately dealing with 
these repeated stressors. So, in depressed patients an increased vulnerability should exist. 
In some cases this will be an intrusive life event, like for example sexual abuse. In other 
cases the genetic makeup of the individual can be held responsible. And perhaps in most 




As a consequence of the kindling hypothesis, one would expect that biological measures 
which have an anticonvulsant effect on the amygdala, also have a therapeutic effect in 
mood disorders. And this appears to be true, at least in case of, for example, 
electroconvulsive therapy (ECT). ECT is believed to exert its therapeutic action on the basis 
of a potent anticonvulsant activity. Treatment with ECT extensively raises the convulsive 
threshold. It can be postulated that this anticonvulsant activity is also exhibited within the 
basolateral amygdala. This would then result in a reversal of the increased excitability of 
this limbic structure.
However, not all anti-kindling treatments result in antidepressant effects. Several 
anticonvulsant drugs for example are primarily active in mania. Their efficacy in the 
treatment of a ‘bipolar’ as well as a ‘unipolar’ depression is at the best doubtful. Only 
electroconvulsive therapy (ECT) appears to be effective during the treatment of both 
depression and mania. Moreover, several effective tricyclic antidepressant drugs have the 
opposite effect; they enhance the vulnerability of the amygdala to kindling. This may 
correspond with their potential to induce mania and ‘rapid cycling’ in bipolar disorder, but 
is not in line with their therapeutic effects in depression. It supports the hypothesis that 
tricyclic antidepressant drugs elicit their therapeutic effects in structures other than the 
hippocampal/amygdala complex. This brings into question whether or not ECT elicits 
antidepressant activity in this brain structure. Its effects on the hippocampus/amygdala  
maybe primarily related to its antimanic activity, while its antidepressive effects are found 
elsewhere.
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In summary, three sites of action may be proposed for various antidepressant treatments, 
and these structures may play an essential role in the pathogenesis of depressive disorders. 
These structures are the hypothalamus, the amygdala/hippocampal complex, and the 
prefrontal cortex. 
The hypothalamus is directly activated by tricyclic antidepressants, which all have a certain 
adrenergic activity. The hypothalamus is activated by the amygdala and this structure may 
play a dominant role in the induction of mood disorders. Several antidepressive treatments 
influence the amygdala, either directly or by enhancing its inhibition. In this last process the 
function of the hippocampus plays a crucial role.
The prefrontal cortex is essential for response selection and motivation to reward bringing 
behavior. It is directly influenced by dopaminergic drugs, but more often addressed 
indirectly by antidepressant drugs.
This brings us back to our original model. Two interacting sites can be identified from 
where the depressive disorder can be thought to originate:
Firstly, depression can be considered to originate from the brain stem, hypothalamus and 
primarily the prefrontal part of the cerebral cortex. These structures regulate the 
autonomic, endocrine and motivational life functions. These structures may cause the lack 
of energy, the lack of motivation, and also lack of pleasure that bothers the depressed 
patient. 
Secondly, depressive symptoms can be thought to originate from the amygdala and 
hippocampal complex. These brain structures regulate our reactions to past and present 
events that endanger us from the outer world. They can be considered to cause the 
negative expectations, the feelings of hopelessness, and also the lack of happiness that 
characterize depression. Depression is also a disorder that troubles its sufferer with 
inappropriate concern.
Thank you very much.
Siberia, May 2013.
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